Dragonfly Therapeutics seeks a highly skilled and experienced Senior/Principal Associate Scientist to join our Translational Medicine team to support the advancement of our clinical programs. The candidate must have extensive experience in design, validation, and analysis of clinical samples using spectral flow cytometry and Luminex technology. We are searching for an independent and flexible individual able to work efficiently across multiple projects.
Responsibilities:

• Play a key role in the progression of Dragonfly's clinical stage programs
• Responsible for the hands-on execution of flow cytometry-based immuno phenotyping and analysis of serum soluble factors from clinical samples
• Develop and validate multicolor flow cytometry panels and Luminex multiplex assays
• Ensure compliance with all regulatory and safety standards in the laboratory
• Generate, analyze, interpret, organize, and report experimental data
• Oversee day to day operations of clinical samples lab, including receive and accession clinical samples following established SOPs
• Collaborate with cross-functional teams to integrate flow cytometry and Luminex data with other biomarker data

Qualifications:

• B.S. or M.S. degree in Immunology, Cell Biology, or a related field (title commensurate with experience)
• Minimum of 5 years of relevant research experience, industry experience is required
• Extensive hands-on experience with developing, validating, and running high-dimensional flow cytometry panels and Luminex assays is required; experience working Cytek Aurora is preferred
• Proficiency with data analysis methods and software (e.g. FlowJo, Excel, GraphPad Prism)
• Familiarity with regulatory requirements and quality control processes in a clinical laboratory setting
• Strong organizational and record-keeping skills, and written and verbal communication skills
• Ability to multi-task with a high attention to detail
• Ability to work in concert with a team as well as independently
• Self-motivated, conscientious, and enthusiastic about curing cancer

About DragonflyDragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas.
Our mission is to revolutionize disease treatment by inventing natural killer cell-based therapies for vastly improved patient outcomes. We believe in a small team with a big impact.